This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Enterprise Products (EPD) Declares 64th Distribution Hike
by Zacks Equity Research
Enterprise Products' (EPD) increased distribution translates to a yield of 6.8% based on its price today.
Enterprise Products (EPD) Beats on Earnings & Revenues in Q4
by Zacks Equity Research
Enterprise Products (EPD) benefits from high revenues across all segments except Natural Gas Pipeline and Services in Q4.
Why Enterprise Products (EPD) Might Surprise This Earnings Season
by Zacks Equity Research
Enterprise Products (EPD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Enterprise (EPD) Hikes Dividend, Banks on Transportation
by Zacks Equity Research
Enterprise's (EPD) raises dividend of 425 cents per common unit for the fourth quarter by 3.7% annually and 5.85% sequentially.
Enterprise to Expand Butane Isomerization Capacity in Texas
by Zacks Equity Research
Backed by long-term agreements, Enterprise (EPD) plans to expand capacity at butane isomerization facility in Mont Belvieu, TX.
Enterprise to Expand Processing Capacity at Orla Facility
by Zacks Equity Research
Enterprise (EPD) plans to increase natural gas processing capacity by 300 MMcf/d at Orla facility.
Enterprise Products (EPD) Plans to Reconstruct NGL Pipelines
by Zacks Equity Research
Enterprise Products (EPD) to modify NGL pipelines stretching from the Permian Basin to the Texas Gulf Coast.
U.S. Crude Export to Asia Swells: Is OPEC Losing the Game?
by Zacks Equity Research
The increase in U.S. oil exports to Asian markets has dented OPEC supplies.
The Zacks Analyst Blog Highlights: CVS Health, General Motors, Enterprise Products, Berkshire Hathaway and PetroChina
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS Health, General Motors, Enterprise Products, Berkshire Hathaway and PetroChina
Top Research Reports for CVS Health, General Motors & Enterprise Products
by Zacks Equity Research
Today's Research Daily features new research reports on 16 major stocks, including CVS Health (CVS), General Motors (GM), and Enterprise Products (EPD).